Showing 1391-1400 of 9427 results for "".
Artefill Overview
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aretfille/19521/A description of Artefill (polymethylmethacrylate (PMMA) microspheres and bovine collagen), patient assessment/consultation, injection technique for dermal filler, and aesthetic progression .DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/dermwiretv-extra-dr-alexandra-golant-atopic-dermatitis-awareness/26574/DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis AwarenessLaser Adoption in Dermatology
https://practicaldermatology.com/series/c-suite-chats/laser-adoption-dermatology/26535/Pavel Efremkin, PhD, Founder and CEO of Aerolase, discusses the state of the laser market in dermatology and the various applications of new technology in the field.Harnessing AI for Dermatology Residents
https://practicaldermatology.com/issues/may-june-2025/harnessing-ai-for-dermatology-residents/35915/Dermatology residents face the dual challenge of delivering high-quality patient care while continually advancing their medical knowledge and research skills.DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.FDA Approves Bimzelx for Hidradenitis Suppurativa
https://practicaldermatology.com/series/dermwire-tv/fda-approves-bimzelx-hidradenitis-suppurativa/29518/In this week's DermwireTV, the FDA approves a new treatment for moderate to severe hidradenitis suppurativa; the FDA agrees to review the resubmission of Dupixent for the treatment of CSU; and the president of Merz Aesthetics, North America, joins us to discuss trends in the aesthetic market.FDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Significant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.Understanding Disparities in AD
https://practicaldermatology.com/series/updates-atopic-dermatitis/understanding-disparities-ad/29081/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks with Practical Dermatology about understanding disparities in atopic dermatitis and the socHow to Approach a Contract Negotiation
https://practicaldermatology.com/series/pa-perspectives/how-approach-contract-negotiation/29072/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, provides tips on how to approach a contract negotiation, including the importance of using objective data while negotiating.